Genesis Therapeutics
Zach Kagin is a Senior ML Research Engineer at Genesis Therapeutics, where Zach utilizes machine learning and computational biochemistry to discover and develop new medicines. Prior to this role, Kagin worked as a Software Engineer at Kagin Consulting and at Frubana, where Zach also served as an advisor. Their extensive experience includes roles at Dropbox, The Boston Consulting Group, and .406 Ventures. Kagin holds a B.S in Physics and a B.A in Economics from Yale University.
This person is not in the org chart
This person is not in any offices
Genesis Therapeutics
3 followers
Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies.